Jenburkt Pharmaceuticals Ltd. | Cash Flow
Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
103,289.00
143,399.00
168,283.00
204,789.00
252,689.00
Depreciation, Depletion & Amortization
15,531.00
26,590.00
19,917.00
17,871.00
15,002.00
Other Funds
724.00
1,167.00
1,861.00
1,305.00
3,275.00
Funds from Operations
91,093.00
122,713.00
127,143.00
153,085.00
181,998.00
Changes in Working Capital
24,190.00
19,510.00
27,592.00
30,120.00
9,731.00
Net Operating Cash Flow
115,283.00
103,203.00
99,551.00
122,965.00
191,729.00
Capital Expenditures
9,613.00
7,943.00
25,272.00
3,724.00
4,535.00
Sale of Fixed Assets & Businesses
634.00
477.00
388.00
1,829.00
169.00
Purchase/Sale of Investments
-
-
3,012.00
122,482.00
20,295.00
Net Investing Cash Flow
8,979.00
7,466.00
27,896.00
125,218.00
24,019.00
Cash Dividends Paid - Total
27,558.00
35,254.00
40,290.00
-
76,613.00
Issuance/Reduction of Debt, Net
26,064.00
45,949.00
11,952.00
9,558.00
61,336.00
Net Financing Cash Flow
52,898.00
11,862.00
50,381.00
10,863.00
175,739.00
Net Change in Cash
53,406.00
107,599.00
21,274.00
8,610.00
8,029.00
Free Cash Flow
105,688.00
95,328.00
76,030.00
119,241.00
187,194.00
Other Sources
-
-
-
-
642.00
Change in Capital Stock
-
-
-
-
34,515.00
Other Uses
-
-
-
841.00
-
About Jenburkt Pharmaceuticals
View Profile
